Wednesday, June 10, 2026

Patent intelligence · EP

EP 4741400

MULTIMERE MANGANKONTRASTMITTEL

granted A61K 31/ 395 A IA61P 43/ 00 A IA61P/4300
Status granted
Years to expiry 20
Applicant portfolio 25
Patent details — EP 4741400
Jurisdiction
EP
Status
granted
Grant date
May 13, 2026
Expiration
May 8, 2046
Applicant
BAYER AG [DE]
CPC classes
A61K 31/ 395 A I, A61P 43/ 00 A I, A61P/4300
View on Google Patents ↗

Quick answer

EP 4741400 (MULTIMERE MANGANKONTRASTMITTEL) is held by BAYER AG [DE]. Status: granted. Granted May 13, 2026. Expires May 8, 2046 (20 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
BAYER AG [DE]
Grant date
Expiration
Claims
CPC classes
A61K 31/ 395 A I, A61P 43/ 00 A I, A61P/4300

More from BAYER AG [DE]

Related pharmaceutical patents in our USPTO index.

  1. WO 2026112109

    TECHNOLOGIE DE PLATEFORME DE GRANULATION PAR VOIE HUMIDE POUR FABRIQUER DES COMPRIMÉS/ARTICLES À MÂCHER MOUS

    BAYER HEALTHCARE LLC [US] · Expires May 23, 2046

    granted
  2. WO 2026106858

    FORMULATIONS ET PROCÉDÉS POUR MAINTENIR UNE SUSPENSION ET UNE VIABILITÉ DE CELLULES

    BAYER HEALTHCARE LLC [US] · Expires May 16, 2046

    granted
  3. WO 2026068294

    PROCESSUS DE NANOENSEMENCEMENT AMÉLIORÉ

    BAYER AG [DE] · Expires Mar 28, 2046

    granted
  4. WO 2026047020

    FORMES CRISTALLINES D'INHIBITEURS DE HER2/MUTEGFR ET LEUR PROCÉDÉ DE PRÉPARATION

    BAYER AG [DE] · Expires Feb 28, 2046

    granted
  5. WO 2026047022

    FORME POSOLOGIQUE PHARMACEUTIQUE SOLIDE ET STABLE COMPRENANT UNE FORME CRISTALLINE D'UN INHIBITEUR DE HER2/MUTEGFR ET SA MÉTHODE DE PRÉPARATION

    BAYER AG [DE] · Expires Feb 28, 2046

    granted
  6. US 20260051027

    GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES

    BAYER AG [DE] · Expires Feb 14, 2046

    granted
  7. WO 2026032865

    SEL D'UN INHIBITEUR DE SOS-1

    BAYER AG [DE] · Expires Feb 7, 2046

    granted

Frequently asked questions

What is US patent 4741400?

EP 4741400 (MULTIMERE MANGANKONTRASTMITTEL) is held by BAYER AG [DE]. Status: granted. Granted May 13, 2026. Expires May 8, 2046 (20 years remaining) — relevant for patent-cliff and LOE planning.

Who owns EP 4741400?

BAYER AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does EP 4741400 expire?

Our index shows an expiration date of May 8, 2046 (20 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.